140 related articles for article (PubMed ID: 30815384)
1. Proniosomal gel-mediated topical delivery of fluconazole: Development,
Abu El-Enin ASM; Khalifa MKA; Dawaba AM; Dawaba HM
J Adv Pharm Technol Res; 2019; 10(1):20-26. PubMed ID: 30815384
[TBL] [Abstract][Full Text] [Related]
2. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
Abdelbary GA; Amin MM; Zakaria MY
Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
[TBL] [Abstract][Full Text] [Related]
3. Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
El-Emam GA; Girgis GNS; El-Sokkary MMA; El-Azeem Soliman OA; Abd El Gawad AEGH
Int J Nanomedicine; 2020; 15():7825-7840. PubMed ID: 33116503
[TBL] [Abstract][Full Text] [Related]
4. Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.
Rajabalaya R; Leen G; Chellian J; Chakravarthi S; David SR
Pharmaceutics; 2016 Aug; 8(3):. PubMed ID: 27589789
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.
Khalil RM; Abdelbary GA; Basha M; Awad GE; El-Hashemy HA
J Liposome Res; 2017 Jun; 27(2):118-129. PubMed ID: 27079800
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of boswellic acid-loaded proniosomal gel.
Mehta M; Dureja H; Garg M
Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
[TBL] [Abstract][Full Text] [Related]
8. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain.
Abdelbary GA; Aburahma MH
J Liposome Res; 2015; 25(2):107-21. PubMed ID: 25058447
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder.
Rajabalaya R; David SR; Chellian J; Xin Yun G; Chakravarthi S
Drug Deliv; 2016 Jun; 23(5):1578-87. PubMed ID: 26634274
[TBL] [Abstract][Full Text] [Related]
10. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
[TBL] [Abstract][Full Text] [Related]
11. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
12. Proniosomes as a Carrier System for Transdermal Delivery of Clozapine.
Tareen FK; Shah KU; Ahmad N; Ur Rehman A; Shah SU; Ullah N
Drug Dev Ind Pharm; 2020 May; ():1-24. PubMed ID: 32362194
[TBL] [Abstract][Full Text] [Related]
13. The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole.
El Laithy HM; El-Shaboury KM
AAPS PharmSciTech; 2002; 3(4):E35. PubMed ID: 12916929
[TBL] [Abstract][Full Text] [Related]
14. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
[TBL] [Abstract][Full Text] [Related]
15. Effect of Formulation Variables and Gamma Sterilization on Transcorneal Permeation and Stability of Proniosomal Gels as Ocular Platforms for Antiglaucomal Drug.
Sayed S; Abdelmoteleb M; Amin MM; Khowessah OM
AAPS PharmSciTech; 2020 Feb; 21(3):87. PubMed ID: 32016607
[TBL] [Abstract][Full Text] [Related]
16. Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction.
Mohamed SA; Rofaeil RR; Salem H; Elrehany M; Asiri YI; Al Fatease A; Abdelkader H
Gels; 2023 Jul; 9(8):. PubMed ID: 37623052
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Optimization of Itraconazole Transferosomes-Loaded HPMC Hydrogel for Enhancing Its Antifungal Activity: 2^3 Full Factorial Design.
Alyahya EM; Alwabsi K; Aljohani AE; Albalawi R; El-Sherbiny M; Ahmed R; Mortagi Y; Qushawy M
Polymers (Basel); 2023 Feb; 15(4):. PubMed ID: 36850278
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application.
Nemr AA; El-Mahrouk GM; Badie HA
Drug Dev Ind Pharm; 2021 Mar; 47(3):403-415. PubMed ID: 33625936
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
[TBL] [Abstract][Full Text] [Related]
20. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
